Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.37 |
| ▸ | PRKDC | P78527 | 2/20 | 0.33 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15870767 | 0.98 | ALOX5 (0.43) | ALOX5GGPS1PRKDCPTGES2KDM4E | |
| SCHEMBL22151189 | 0.97 | ALOX5 (0.42) | ALOX5GGPS1PRKDCPTGES2KDM4E | |
| SCHEMBL17855555 | 0.97 | ALOX5 (0.44) | ALOX5GGPS1PRKDCPTGES2KDM4E | |
| SCHEMBL17855534 | 0.97 | ALOX5 (0.44) | ALOX5GGPS1PRKDCPTGES2KDM4E | |
| SCHEMBL21923947 | 0.96 | ALOX5 (0.41) | ALOX5GGPS1PRKDCPTGES2KDM4E | |
| SCHEMBL17804646 | 0.96 | ALOX5 (0.43) | ALOX5GGPS1PRKDCPTGES2KDM4E | |
| SCHEMBL17903166 | 0.96 | ALOX5 (0.43) | ALOX5GGPS1PRKDCPTGES2KDM4E | |
| SCHEMBL17855579 | 0.96 | ALOX5 (0.43) | ALOX5GGPS1PRKDCPTGES2KDM4E | |
| SCHEMBL17855593 | 0.96 | ALOX5 (0.43) | ALOX5GGPS1PRKDCPTGES2KDM4E | |
| SCHEMBL16810764 | 0.96 | ALOX5 (0.44) | ALOX5GGPS1PRKDCPTGES2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200131112-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | LG CHEM, LTD. (KR) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200131112-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | AOX1, CYP1B1, CRY1 | ALOX5 230/4885GGPS1 49/4885PRKDC 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.